Medical Director

InnoCare Pharma; United States; On-site; USD 150,000 - 230,000; Full time

Job summary

InnoCare Pharma, a biopharmaceutical company committed to discovering, developing, and commercializing innovative drugs for cancer and autoimmune diseases, seeks an MD with hands-on experience leading phase I–III clinical trials in autoimmune diseases or hematology-oncology to guide trial design and execution.

You will supervise trials, ensure adherence to ICH-GCP and SOPs, and coordinate with investigators, ethics committees, regulatory authorities and CROs to deliver high-quality data on

Qualifications

• 3+ years direct experience in autoimmune and/or Hema-oncology clinical trials.
• Experience in study design, trial implementation, medical monitoring, data integrity and interpretation in CRO/pharma environments.
• Knowledge of local and global regulatory requirements and GCP standards.

Responsibilities

• Design phase I–III clinical trials in autoimmune or hematology-oncology per ICH-GCP.
• Supervise trials ensuring protocols, SOPs, GCP and regulatory compliance.
• Build and maintain relationships with investigators via regular communications and visits.
• Collaborate with internal stakeholders and external partners to ensure progress within timelines and quality.
• Communicate with ethics committees, clinical research institutions, patient groups, and regulators at all levels.
• Provide medical development support including monitoring, data interpretation, safety committees participation, and regulatory communications.

Skills

Inter-personal skills

Communication skills

Education

MD (Doctor of Medicine)

Job description

InnoCare (HKEX: 09969; SSE: 688428) is a commercial stage biopharmaceutical company committed to discovering, developing, and commercializing innovative drugs for the treatment of cancers and autoimmune disease, with unmet medical needs worldwide. InnoCare has built up a fully integrated platform in terms of research and development, clinical development, manufacturing and commercialization.

To date, the Company has developed a robust product pipeline comprising three approved drugs (orelabrutinib, tafasitamab and zurletrectinib), and more than ten innovative drug candidates in clinical development, and multiple programs in preclinical stages. InnoCare has successfully got listed on both Hong Kong Stock Exchange and the STAR Board of Shanghai Stoch Exchange. Our world-class team exhibits remarkable synergy and efficient execution, with entrepreneurial spirit, which has made outstanding achievements in innovation, commercialization and globalization.

If you would like to join us, we will develop innovative drugs for the benefit of patients worldwide. Website link: https://www.innocarepharma.com/en. LinkedIn: InnoCare Pharma.

Key Responsibilties

• Designing and implementing phase I-II-III clinical trials in the field of Hema-oncology or autoimmune, based on ICH-GCP and relevant clinical research guidelines.
• Responsible for supervising clinical trials, ensuring that protocols, standard operating procedures SOP’s, good manufacturing practices (GCP) and regulatory requirements are followed.
• Building and maintain relationship with study investigators through regular communications and in-person visits.
• Collaborating with internal stakeholders and external partners in ensuring progress and delivery of clinical trials under defined timelines and with quality.
• Maintaining effective communication and cooperation with investigators, ethics committees, clinical research institutions, patient groups, and regulatory authorities at all levels in accordance with relevant policies and regulations.
• Medical development responsibilities, including medical monitoring and training during clinical trials; data integrity; data interpretation and analysis; participation in safety committees; communicating with regulatory authorities on medical related topics; and writing medical research documents for registration or publication.

Requirements

• Doctor’s degree in Medicine (MD) required. Minimum of 3 years’ direct experience of clinical trials in the field of autoimmune and/or Hema-oncology fields; familiar with design and execution of phase I to III trials.
• Relevant work experience in study design, trial implementation, medical monitoring, data integrity and interpretation in a CRO, pharmaceutical or clinical trial environment required.
• Knowledge of both local and global regulatory requirements as well as local and global GCP requirements.
• Strong written and verbal communication and inter-personal skills to work with internal stakeholders or external partners.
• Flexibility with work assignments and working hours; night-time TC with corporate functions in China.